Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 11/20 | 0.90 |
| ▸ | AVPR1A | P37288 | 5/20 | 0.90 |
| ▸ | AVPR1B | P47901 | 4/20 | 0.90 |
| ▸ | AVPR2 | P30518 | 3/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL122621 | 1.00 | OXTR (0.90) | OXTRAVPR1AAVPR1BAVPR2 | |
| Aspartocin SCHEMBL29439933 | 0.98 | OXTR (0.94) | OXTRAVPR1AAVPR1BAVPR2 | |
| Aspartocin SCHEMBL2398841 | 0.98 | OXTR (0.94) | OXTRAVPR1AAVPR1BAVPR2 | |
| Aspartocin SCHEMBL193132 | 0.98 | OXTR (0.94) | OXTRAVPR1AAVPR1BAVPR2 | |
| Oxytocin SCHEMBL29048 | 0.95 | OXTR (1.00) | OXTRAVPR1AAVPR1BAVPR2 | |
| Oxytocin SCHEMBL21527573 | 0.95 | OXTR (1.00) | OXTRAVPR1AAVPR1BAVPR2 | |
| SCHEMBL15512173 | 0.95 | OXTR (0.92) | OXTRAVPR1AAVPR1BAVPR2 | |
| Oxytocin SCHEMBL20707334 | 0.95 | OXTR (1.00) | OXTRAVPR1AAVPR1BAVPR2 | |
| Oxytocin SCHEMBL1173243 | 0.95 | OXTR (1.00) | OXTRAVPR1AAVPR1BAVPR2 | |
| Oxytocin SCHEMBL16373316 | 0.95 | OXTR (1.00) | OXTRAVPR1AAVPR1BAVPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-12569624-B2 | Devices, methods and compositions for reproductive organs | FEMASYS INC. (US) | 2026-03-10 | — | — | US | claimed |
| US-20260007571-A1 | PHARMACEUTICAL CONTAINER WITH PH PROTECTIVE LAYER DEPOSITED BY ATOMIC LAYER DEPOSITION | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2026-01-08 | — | — | US | claimed |
| WO-2025245470-A1 | SYRINGE WITH BUILT-IN LUBRICATION FOR MEDICAL USE | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| US-12447107-B2 | Pharmaceutical container with pH protective layer deposited by atomic layer deposition | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-10-21 | — | — | US | claimed |
| US-20250248896-A1 | PHARMACEUTICAL CONTAINER WITH PH PROTECTIVE LAYER DEPOSITED BY ATOMIC LAYER DEPOSITION | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-08-07 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| US-12303461-B1 | Pharmaceutical container with pH protective layer deposited by atomic layer deposition | INNOVATIVE SCIENTIFIC PRODUCTS, INC. (US) | 2025-05-20 | — | — | US | claimed |
| US-12257371-B2 | SiOx barrier for pharmaceutical package and coating process | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-25 | — | — | US | claimed |
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | EXTREMOCHEM, LDA. (PT) | 2025-02-13 | — | — | US | claimed |
| US-11724860-B2 | Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus | SIO2 MEDICAL PRODUCTS, INC. (US) | 2023-08-15 | — | — | US | claimed |
| US-11684546-B2 | PECVD coated pharmaceutical packaging | SIO2 MEDICAL PRODUCTS, INC. (US) | 2023-06-27 | — | — | US | claimed |
| EP-4188996-A1 | METHOD AND PACKAGE FOR REDUCING THE DEGRADATION OF A DRUG AND/OR EXCIPIENT, E.G. POLYSORBATE STABILIZER, IN A PHARMACEUTICAL PRODUCT | SiO2 Medical Products, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| EP-4168068-A1 | ATOMIC LAYER DEPOSITION COATED PHARMACEUTICAL PACKAGING AND IMPROVED SYRINGES AND VIALS, E.G. FOR LYOPHILIZED/COLD-CHAIN DRUGS/VACCINES | SiO2 Medical Products, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| WO-2023039229-A1 | DEVICES, METHODS AND COMPOSITIONS FOR REPRODUCTIVE ORGANS | FEMASYS INC. (US) | 2023-03-16 | — | — | WO | claimed |
| US-20220244247-A1 | PECVD COATED PHARMACEUTICAL PACKAGING | OAKTREE FUND ADMINISTRATION, LLC | 2022-08-04 | — | — | US | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| WO-2022109619-A1 | POLYMER VIALS HAVING STANDARD EXTERNAL DIMENSIONS AND REDUCED INTERNAL VOLUME | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-05-27 | — | — | WO | claimed |
| US-20220161969-A1 | PASSIVATION, pH PROTECTIVE OR LUBRICITY COATING FOR PHARMACEUTICAL PACKAGE, COATING PROCESS AND APPARATUS | OAKTREE FUND ADMINISTRATION, LLC | 2022-05-26 | — | — | US | claimed |
| US-11298293-B2 | PECVD coated pharmaceutical packaging | SIO2 MEDICAL PRODUCTS, INC. (US) | 2022-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007571-A1 | PHARMACEUTICAL CONTAINER WITH PH PROTECTIVE LAYER DEPOSITED BY ATOMIC LAYER DEPOSITION | CFD, SLC9B2, SETD1B | OXTR 4644/4885AVPR1A 3257/4885AVPR1B 1057/4885 |
| US-12569624-B2 | Devices, methods and compositions for reproductive organs | PGF, GNRHR, PROX1 | OXTR 50/4885AVPR1A 505/4885AVPR1B 563/4885 |
| US-20250051384-A1 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | FUT6, GUSB, UGGT1 | OXTR 3074/4885AVPR1A 1161/4885AVPR1B 1496/4885 |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | MEN1, MYO1G, IL2 | OXTR 4568/4885AVPR1A 2066/4885AVPR1B 1648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.